[{"indications": "Indications\u00a0adjunct to quinine in treatment of Plasmodium falciparum malaria; not recommended for prophylaxis", "name": "PYRIMETHAMINE WITH SULFADOXINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.4 Antiprotozoal drugs", "5.4.1 Antimalarials", "Pyrimethamine"], "cautions": "Cautions\u00a0see under Pyrimethamine and under Co-trimoxazole (section 5.1.8); not recommended\r\nfor prophylaxis (severe side-effects on long-term use); interactions: Appendix 1 (pyrimethamine, sulfonamides)", "side-effects": "Side-effects\u00a0see under Pyrimethamine and\r\nunder Co-trimoxazole (section 5.1.8); pulmonary infiltrates (e.g.\r\neosinophilic or allergic alveolitis) reported\u2014discontinue if cough\r\nor shortness of breath", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/33618.htm", "doses": ["Treatment of falciparum malaria, see notes above", "Prophylaxis, not recommended by UK malaria experts"], "pregnancy": "Pregnancy\u00a0possible teratogenic risk in first trimester (pyrimethamine a folate antagonist); in third trimester\u2014risk of neonatal haemolysis and methaemoglobinaemia;\r\nfear of increased risk of kernicterus in neonates appears to be unfounded;\r\nsee also Falciparum Malaria (treatment)"}]